2- (4- nitrophenyl)- 4- (4- fluorophenyl)- 5- (4- pyridinyl)- 1H- imidazole
p38 MAP kinase inhibitor
Also Known As:
4-(4-fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole; PD 169316; PD-169316; PD168316; PD169316; Pyridine, 4-(4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl)-
Networked: 10
relevant articles (1 outcomes,
2 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Cambier, Ludivine:
1 article
(10/2019)
|
2. | De Vuyst, Evelyne:
1 article
(10/2019)
|
3. | Evrard, Céline:
1 article
(10/2019)
|
4. | Faway, Emilie:
1 article
(10/2019)
|
5. | Lambert de Rouvroit, Catherine:
1 article
(10/2019)
|
6. | Mignon, Bernard:
1 article
(10/2019)
|
7. | Poumay, Yves:
1 article
(10/2019)
|
8. | Thiry, Marc:
1 article
(10/2019)
|
9. | Jeong, Hoiseon:
1 article
(08/2013)
|
10. | Kim, Aeree:
1 article
(08/2013)
|
Related Diseases
Related Drugs and Biologics